FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

30719811000001105: Abtard 10mg modified-release tablets (DB Ashbourne Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94151801000001119 Abtard 10mg modified-release tablets (DB Ashbourne Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101223201000001113 Abtard 10mg modified-release tablets (Ethypharm UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Is a Oxycodone hydrochloride 10mg m/r tablet false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Is a Abtard true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Is a Oxycodone 10mg modified-release tablets false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Is a Oxycodone 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Abtard 10mg modified-release tablets (DB Ashbourne Ltd) 56 tablet 4 x 14 tablets Has AMP True Abtard 10mg modified-release tablets (DB Ashbourne Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start